Cardiac Mapping Market Report 2026

Cardiac Mapping Market Overview

• Cardiac Mapping market size has reached to $2.47 billion in 2025 • Expected to grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: The Prevalence Of Heart Ailments Fuels Cardiac Mapping Market • Market Trend: Technological Advancements in the Cardiac Mapping Market to Enhance Procedural Accuracy and Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac Mapping Market?

Cardiac mapping refers to the process of creating a detailed representation of the electrical activity within the heart. It helps identify abnormal heart rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This information is crucial for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats. The main types of cardiac mapping are contact cardiac mapping systems and non-contact cardiac mapping systems. Contact cardiac mapping systems refer to devices that use electrodes in direct contact with the heart tissue to precisely identify and map electrical activity for diagnosing and treating arrhythmias. These systems are indicated for conditions such as atrial fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), and others. End users include hospitals and clinics, diagnostic centers, and other healthcare facilities.

What Is The Cardiac Mapping Market Growth Forecast?

The cardiac mapping market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing integration of ai-assisted mapping algorithms, expansion of complex arrhythmia treatment, growing investment in electrophysiology infrastructure, rising demand for precision-guided ablation, increasing adoption of advanced visualization platforms. Major trends in the forecast period include increasing adoption of 3d cardiac mapping systems, rising use of real-time electrophysiology mapping, growing integration of mapping with ablation procedures, expansion of non-contact mapping technologies, enhanced focus on procedural accuracy.

Global Cardiac Mapping Market Segmentation

1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems 2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications 3) By End-User: Hospitals And Clinics, Diagnostic Centers Subsegments: 1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems, Catheter-Based Mapping Systems, Integrated Mapping And Ablation Systems, 3D Mapping Systems 2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems, Electrocardiographic Mapping Systems

What Is The Driver Of The Cardiac Mapping Market?

The prevalence of heart ailments is expected to propel the growth of the cardiac mapping market going forward. Heart ailments refer to various conditions or diseases that affect the heart's structure and function, leading to complications such as arrhythmias, heart attacks, and heart failure. Increasing cases of heart ailments can be attributed to factors such as sedentary lifestyles, poor dietary habits, and aging populations. Cardiac mapping helps diagnose and treat heart ailments by precisely identifying electrical abnormalities in the heart's rhythm. For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, the prevalence of heart ailments is driving the growth of the cardiac mapping industry.

Key Players In The Global Cardiac Mapping Market

Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., GE Healthcare Technologies, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology Co. Ltd., Acutus Medical Inc., Kardium Inc., BioSig Technologies Inc., Catheter Precision Inc., EP Solutions SA, CoreMap Inc., Navix Medical Ltd., EPmap-System, Stereotaxis Inc., CathVision ApS, Baylis Medical Company Inc.

Global Cardiac Mapping Market Trends and Insights

Major companies operating in the cardiac mapping market are focusing on developing innovative solutions such as pulsed field ablation to improve the precision, safety, and efficacy of cardiac arrhythmia treatments. Pulsed Field Ablation (PFA) refers to a non-thermal cardiac ablation technique that uses high-voltage, short electrical pulses to create microscopic pores in heart tissue cells (electroporation), selectively destroying abnormal cardiac cells responsible for arrhythmias while minimizing damage to surrounding healthy tissue. For instance, in October 2024, Medtronic Plc, an Ireland-based technology company, received FDA approval for the Affera™ Mapping and Ablation System along with the Sphere-9 Catheter. This system is an all-in-one, high-density mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter designed for treating persistent atrial fibrillation (AFib) and cavotricuspid isthmus (CTI) dependent atrial flutter.

What Are Latest Mergers And Acquisitions In The Cardiac Mapping Market?

In November 2024, Boston Scientific Corporation, a US-based provider of medical devices and electrophysiology solutions, acquired Cortex, Inc. for an undisclosed amount. With this acquisition, Boston Scientific aims to integrate Cortex’s OptiMap electrographic-flow mapping technology to enhance its cardiac-mapping capabilities, especially for complex AF (atrial fibrillation) cases. Cortex, Inc. is a US-based company developing advanced cardiac mapping systems, including the OptiMap system for improved localization of arrhythmia sources.

Regional Outlook

North America was the largest region in the cardiac mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac Mapping Market?

The cardiac mapping market consists of revenues earned by entities by providing services such as monitoring and follow-up, diagnostic mapping, and ablation guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac mapping market also includes sales of electrophysiology mapping systems, mapping software, navigation systems, and ablation catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiac Mapping Market Report 2026?

The cardiac mapping market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac mapping industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.